Team
Our Mission: Let Every Single Cell Tell Its Story
About Us
BioSkryb has ushered in a whole new era of single-cell whole genome amplification. The benefits of the BioSkryb ResolveDNA® technology include the ability to control the amplicon size during amplification. Our complete workflow solution is especially useful in cancer research, as it allows the detection of single resistant mutant cells in heterogeneous cancers such as leukemia. It also enables new applications for gene sequencing that need a level of resolution simply not available today.
Meet our Team
Together, the diverse team at BioSkryb brings a depth of experience in the development of highly sensitive and accurate tools for single-cell analysis, focused on the research and translational needs of new applications that enable improved health management. The company has been rapidly building the infrastructure to make those tools widely available to the research community and others.
BioSkryb’s leadership team has decades of combined scientific and management experience that together sparks the innovations that will change the future of science.
Executive Leadership
Suresh Pisharody
Chief Executive Officer / Board of Directors / BioSkryb Genomics
Suresh Pisharody is a seasoned executive with a proven track record of building world class businesses and teams in the genomics and molecular diagno…
Chuck Gawad, MD, PhD
Chief Scientific Officer / Co-Founder / Scientific Advisory Board / Board of Directors BioSkryb Genomics / Associate Professor of Pediatrics Standford University / Chan Zuckerberg Biohub Investigator
Chuck is a Chan Zuckerberg Biohub Investigator, as well as an Associate Professor of Pediatrics at Stanford University where he has an active researc…
Beverly Himes
Chief Financial Officer
Beverly (Bev) Himes is the acting Chief Financial Officer at BioSkryb Genomics. She is also Vice President, Finance and Government Accounting for Anz…
Scientific Advisory Board
William E. Evans, PharmD
Chair of Scientific Advisory Board / Emeritus Faculty Member in Pharmacogenomics St. Jude Children’s Research Hospital (SJCRH) / Former President and CEO of SJCRH
Dr. Evans joined St. Jude Children’s Research Hospital (SJCRH) as a student in 1972, joined the faculty in 1976, chaired the Pharmaceutical Sciences …
Stefan M. Pfister, MD
Director Preclinical Pediatric Oncology Hopp Children's Cancer Center Heidelberg (KiTZ) / Division Head Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) / Deputy Head KiTZ Clinical Trial Unit and Brain Tumors
Stefan Pfister serves as Director of the Preclinical Research Program of the new Hopp Children's Cancer Center Heidelberg, a joint venture betwe…
Michael B. Kastan, MD, PhD
Executive Director Duke Cancer Institute / William and Jane Shingleton Professor of Pharmacology and Cancer Biology / Duke Cancer Institute in the School of Medicine / Professor of Pediatrics at Duke University
He is the William and Jane Shingleton Professor of Pharmacology and Cancer Biology and Professor of Pediatrics at Duke University and serves as the E…
Peter Park, PhD
Professor of Biomedical Informatics / Director of Bioinformatics and Integrative Genomics PhD program / Harvard Medical School
Dr. Park is a professor of biomedical informatics at Harvard Medical School and the director of its Bioinformatics and Integrative Genomics PhD progr…
Chuck Gawad, MD, PhD
Chief Scientific Officer / Co-Founder / Scientific Advisory Board / Board of Directors BioSkryb Genomics / Associate Professor of Pediatrics Standford University / Chan Zuckerberg Biohub Investigator
Chuck is a Chan Zuckerberg Biohub Investigator, as well as an Associate Professor of Pediatrics at Stanford University where he has an active researc…
Christopher Walsh, MD, PhD
Chief of the Division of Genetics and Genomics Boston Children's Hospital / Investigator of the Howard Hughes Medical Institute (HHMI) / Bullard Professor of Neurology and Pediatrics Harvard Medical School
Dr. Walsh is Chief of the Division of Genetics and Genomics at Boston Children’s Hospital, an Investigator of the Howard Hughes Medical Institute (HH…
Irene Ghobrial, MD
Senior Vice President for Experimental Medicine / Director of the Center for Early Detection and Interception of Blood Cancers / Lavine Family Chair for Preventative Cancer Therapies / Director of the Ghobrial Lab at the Dana-Farber Cancer Institute
Dr. Ghobrial is the Senior Vice President for Experimental Medicine; Director of the Center for Early Detection and Interception of Blood Cancers; La…
Dan Landau, MD, PhD
Professor of Medicine, Division of Hematology and Medical Oncology / Professor of Physiology and Biophysics Weill Cornell Medical School / Core Faculty Member New York Genome Center
Dan A. Landau, MD, PhD, is a Core Faculty Member at the New York Genome Center. He holds a joint appointment as Associate Professor of Medicine in th…
Ruben van Boxtel, PhD
Group Leader Princess Máxima Center for Pediatric Oncology / Professor of Stem Cell Genomics, Faculty of Veterinary Medicine Utrecht University / Oncode Investigator Oncode Institute
Ruben van Boxtel is Group Leader at the Princess Máxima Center for Pediatric Oncology and Professor of Stem Cell Genomics at the Faculty of Veterinar…
Dr. Jyoti Nangalia
Group Leader Wellcome Sanger Institute and Stem Cell Institute / Consultant Haemato-oncologist Cambridge University NHS Trust, UK
Dr Jyoti Nangalia received her medical degree and first class BA from Cambridge University. She subsequently trained clinically in haematology and ha…
Board of Directors
David Michael
Executive Board Chairman and Managing Partner - Anzu Partners
David Michael is an investor and advisor with nearly 30 years of international business experience. He co-founded Anzu Partners and developed the fir…
William E. Evans, PharmD
Chair of Scientific Advisory Board / Emeritus Faculty Member in Pharmacogenomics St. Jude Children’s Research Hospital (SJCRH) / Former President and CEO of SJCRH
Dr. Evans joined St. Jude Children’s Research Hospital (SJCRH) as a student in 1972, joined the faculty in 1976, chaired the Pharmaceutical Sciences …
Suresh Pisharody
Chief Executive Officer / Board of Directors / BioSkryb Genomics
Suresh Pisharody is a seasoned executive with a proven track record of building world class businesses and teams in the genomics and molecular diagno…
Chuck Gawad, MD, PhD
Chief Scientific Officer / Co-Founder / Scientific Advisory Board / Board of Directors BioSkryb Genomics / Associate Professor of Pediatrics Standford University / Chan Zuckerberg Biohub Investigator"
Chuck is a Chan Zuckerberg Biohub Investigator, as well as an Associate Professor of Pediatrics at Stanford University where he has an active researc…
Peter Silvester
Board of Directors
Peter Silvester has over 25 years of experience in the life sciences tools industry and most recently served as a Senior Vice President and President…